FRAGMENT-BASED DRUG DESIGN TO INHIBIT DNA METHYLTRANSFERASE 1 (DNMT1) FOR BREAST CANCER THERAPY. INTERNATIONAL JOURNAL OF GEOMATE 2019, 17 (62), 35-40.